- Kezar Life Sciences Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2023
- Kezar Life Sciences Inc at Wells Fargo Healthcare Conference TranscriptSep 07, 2023
- Kezar Life Sciences Inc at Jefferies Healthcare Conference TranscriptJun 08, 2023
- Kezar Life Sciences Inc R&D Day TranscriptMar 15, 2023
- Alpine Immune Sciences Inc and Kezar Life Sciences Inc at Cowen Health Care Conference- Panel TranscriptMar 07, 2023
- Kezar Life Sciences Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2023
- Kezar Life Sciences Inc at Evercore ISI HealthCONx Conference (Virtual) TranscriptNov 30, 2022
- Kezar Life Sciences Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 14, 2022
- Kezar Life Sciences Inc Topline Results from the MISSION Phase 2 Clinical Trial Evaluating Zetomipzomib - Corporate Call TranscriptJun 27, 2022
- Kezar Life Sciences Inc Annual Shareholders Meeting TranscriptJun 25, 2021
- Kezar Life Sciences Inc At TMA's International Annual Patient Conference TranscriptSep 22, 2020
- Q2 2020 Kezar Life Sciences Inc Earnings Call TranscriptAug 05, 2020$4.72 (+1.83%)Earnings
- Kezar Life Sciences Inc At MSU: Rare Disease Day Presentation TranscriptApr 15, 2020
- Kezar Life Sciences Inc At PRESIDIO Clinical Trial of KZR-616 TranscriptMar 05, 2020
Kezar Life Sciences Inc Annual Shareholders Meeting Transcript
Greetings, and welcome to the Annual Meeting of Kezar Life Sciences. At this time our participants are in listen only mode. A brief question-and-answer session will follow the formal business of this meeting. The question may be submitted in [biding] using the online portal. As a reminder, this meeting is being recorded. It is now my pleasure to introduce today's host, John Fowler. Thank you. You may begin.
Thank you, and good afternoon, ladies and gentlemen. I'm John Fowler, CEO of Kezar Life Sciences and this meeting is called to order. It's my pleasure on behalf of the Board of Directors and management of Kezar to extend you a warm welcome and express our appreciation for attending this meeting. We've already supplied each stockholder with a copy of our proxy statement and annual report. And electronic copies are available on the virtual meeting platform to any stockholder who doesn't have one.
The principal business of this meeting is to consider and vote upon two matters set forth in
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)